1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Afatinib 1.2.3 Trastuzumab 1.2.4 Other 1.3 Market by Application 1.3.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Squamous Cell Carcinoma of NSCLC 1.3.3 Adenocarcinoma of NSCLC 1.3.4 Large Cell Carcinoma of NSCLC 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Perspective (2016-2027) 2.2 Targeted Drug HER2 Inhibitors for NSCLC Growth Trends by Regions 2.2.1 Targeted Drug HER2 Inhibitors for NSCLC Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Targeted Drug HER2 Inhibitors for NSCLC Historic Market Share by Regions (2016-2021) 2.2.3 Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Regions (2022-2027) 2.3 Targeted Drug HER2 Inhibitors for NSCLC Industry Dynamic 2.3.1 Targeted Drug HER2 Inhibitors for NSCLC Market Trends 2.3.2 Targeted Drug HER2 Inhibitors for NSCLC Market Drivers 2.3.3 Targeted Drug HER2 Inhibitors for NSCLC Market Challenges 2.3.4 Targeted Drug HER2 Inhibitors for NSCLC Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Revenue 3.1.1 Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Revenue (2016-2021) 3.1.2 Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Players (2016-2021) 3.2 Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Targeted Drug HER2 Inhibitors for NSCLC Revenue 3.4 Global Targeted Drug HER2 Inhibitors for NSCLC Market Concentration Ratio 3.4.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug HER2 Inhibitors for NSCLC Revenue in 2020 3.5 Targeted Drug HER2 Inhibitors for NSCLC Key Players Head office and Area Served 3.6 Key Players Targeted Drug HER2 Inhibitors for NSCLC Product Solution and Service 3.7 Date of Enter into Targeted Drug HER2 Inhibitors for NSCLC Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Targeted Drug HER2 Inhibitors for NSCLC Breakdown Data by Type 4.1 Global Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Type (2016-2021) 4.2 Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) 5 Targeted Drug HER2 Inhibitors for NSCLC Breakdown Data by Application 5.1 Global Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Application (2016-2021) 5.2 Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) 6.2 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type 6.2.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2021) 6.2.2 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2022-2027) 6.2.3 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2027) 6.3 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application 6.3.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2021) 6.3.2 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2022-2027) 6.3.3 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2027) 6.4 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country 6.4.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2021) 6.4.2 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) 7.2 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type 7.2.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2021) 7.2.2 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2022-2027) 7.2.3 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2027) 7.3 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application 7.3.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2021) 7.3.2 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2022-2027) 7.3.3 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2027) 7.4 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country 7.4.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2021) 7.4.2 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) 8.2 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type 8.2.1 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2027) 8.3 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application 8.3.1 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2027) 8.4 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region 8.4.1 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) 9.2 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type 9.2.1 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2021) 9.2.2 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2022-2027) 9.2.3 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2027) 9.3 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application 9.3.1 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2021) 9.3.2 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2022-2027) 9.3.3 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2027) 9.4 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country 9.4.1 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2021) 9.4.2 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size (2016-2027) 10.2 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type 10.2.1 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2027) 10.3 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application 10.3.1 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2027) 10.4 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country 10.4.1 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Boehringer-Ingelheim 11.1.1 Boehringer-Ingelheim Company Details 11.1.2 Boehringer-Ingelheim Business Overview 11.1.3 Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Introduction 11.1.4 Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2016-2021) 11.1.5 Boehringer-Ingelheim Recent Development 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Targeted Drug HER2 Inhibitors for NSCLC Introduction 11.2.4 Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2016-2021) 11.2.5 Roche Recent Development 11.3 Mylan 11.3.1 Mylan Company Details 11.3.2 Mylan Business Overview 11.3.3 Mylan Targeted Drug HER2 Inhibitors for NSCLC Introduction 11.3.4 Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2016-2021) 11.3.5 Mylan Recent Development 11.4 Biocon 11.4.1 Biocon Company Details 11.4.2 Biocon Business Overview 11.4.3 Biocon Targeted Drug HER2 Inhibitors for NSCLC Introduction 11.4.4 Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2016-2021) 11.4.5 Biocon Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Afatinib Table 3. Key Players of Trastuzumab Table 4. Key Players of Other Table 5. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions (2016-2021) Table 9. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions (2022-2027) Table 11. Targeted Drug HER2 Inhibitors for NSCLC Market Trends Table 12. Targeted Drug HER2 Inhibitors for NSCLC Market Drivers Table 13. Targeted Drug HER2 Inhibitors for NSCLC Market Challenges Table 14. Targeted Drug HER2 Inhibitors for NSCLC Market Restraints Table 15. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Players (2016-2021) Table 17. Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2020) Table 18. Ranking of Global Top Targeted Drug HER2 Inhibitors for NSCLC Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Targeted Drug HER2 Inhibitors for NSCLC Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Targeted Drug HER2 Inhibitors for NSCLC Product Solution and Service Table 22. Date of Enter into Targeted Drug HER2 Inhibitors for NSCLC Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2021) (US$ Million) Table 25. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2016-2021) Table 26. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Application (2016-2021) Table 30. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2021) (US$ Million) Table 33. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2021) (US$ Million) Table 35. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 62. Boehringer-Ingelheim Company Details Table 63. Boehringer-Ingelheim Business Overview Table 64. Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Product Table 65. Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2016-2021) & (US$ Million) Table 66. Boehringer-Ingelheim Recent Development Table 67. Roche Company Details Table 68. Roche Business Overview Table 69. Roche Targeted Drug HER2 Inhibitors for NSCLC Product Table 70. Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2016-2021) & (US$ Million) Table 71. Roche Recent Development Table 72. Mylan Company Details Table 73. Mylan Business Overview Table 74. Mylan Targeted Drug HER2 Inhibitors for NSCLC Product Table 75. Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2016-2021) & (US$ Million) Table 76. Mylan Recent Development Table 77. Biocon Company Details Table 78. Biocon Business Overview Table 79. Biocon Targeted Drug HER2 Inhibitors for NSCLC Product Table 80. Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2016-2021) & (US$ Million) Table 81. Biocon Recent Development Table 82. Research Programs/Design for This Report Table 83. Key Data Information from Secondary Sources Table 84. Key Data Information from Primary Sources List of Figures Figure 1. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type: 2020 VS 2027 Figure 2. Afatinib Features Figure 3. Trastuzumab Features Figure 4. Other Features Figure 5. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application: 2020 VS 2027 Figure 6. Squamous Cell Carcinoma of NSCLC Case Studies Figure 7. Adenocarcinoma of NSCLC Case Studies Figure 8. Large Cell Carcinoma of NSCLC Case Studies Figure 9. Targeted Drug HER2 Inhibitors for NSCLC Report Years Considered Figure 10. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions: 2020 VS 2027 Figure 13. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions (2022-2027) Figure 14. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Players in 2020 Figure 15. Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Targeted Drug HER2 Inhibitors for NSCLC Revenue in 2020 Figure 17. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2016-2021) Figure 18. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2022-2027) Figure 19. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2016-2027) Figure 21. North America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2016-2027) Figure 22. North America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 23. United States Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2016-2027) Figure 27. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2016-2027) Figure 28. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 29. Germany Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2016-2027) Figure 37. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2016-2027) Figure 38. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region (2016-2027) Figure 39. China Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2016-2027) Figure 47. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2016-2027) Figure 48. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 49. Mexico Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2016-2027) Figure 53. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2016-2027) Figure 54. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 55. Turkey Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Boehringer-Ingelheim Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2016-2021) Figure 59. Roche Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2016-2021) Figure 60. Mylan Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2016-2021) Figure 61. Biocon Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2016-2021) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

Boehringer-Ingelheim Roche Mylan Biocon